Showing results (931-940 of 1,075) with videos related to

Sort By:
Pageof 108
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 10, 2015
Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II studyShimpei Nakatani, Yoshinobu Onuma, Yuki Ishibashi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 14, 2009
Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registryDavide Capodanno, Maria Elena Di Salvo, Tullio Palmerini, et al.
European Heart Journal|March 7, 2023
Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statementGill Louise Buchanan, Valeria Paradies, Nicole Karam, et al.
American Heart Journal|November 2, 2025
Rationale and design of REAC-TAVI 2: Single antiplatelet treatment with ticagrelor vs aspirin after transcatheter aortic valve implantationKimberley I Hemelrijk, Victor A Jimenez-Diaz, Jean Paul Vilchez, et al.
JACC. Cardiovascular Interventions|July 9, 2021
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCIDominick J Angiolillo, Davide Cao, Usman Baber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trialMauro Gitto, Usman Baber, Samantha Sartori, et al.
Clinical Pharmacology and Therapeutics|September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionCraig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Journal of the American College of Cardiology|November 19, 2021
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCIMarco Valgimigli, Davide Cao, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions|June 17, 2019
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary InterventionDirk Sibbing, Daniel Aradi, Dimitrios Alexopoulos, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 31, 2020
Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trialAnne H Tavenier, Renicus S Hermanides, Jan Paul Ottervanger, et al.
Pageof 108